Biomedical Science Letters

eISSN 2288-7415

Table. 3.

The number of adverse events by vaccines introduced in Korea

Total cases Mild adverse events Anaphylaxis shock AESI Deaths
AZ 109,486 103,830 (94.83%) 331 (0.30%) 4,894 (4.47%) 431 (0.39%)
Janssen 8,847 8,444 (95.44%) 54 (0.61%) 335 (3.79%) 14 (0.16%)
Pfizer 235,444 225,998 (95.99%) 1,260 (0.54%) 7,344 (3.12%) 842 (0.36%)
Moderna 110,288 107,841 (97.78%) 292 (0.26%) 1,938 (1.76%) 217 (0.20%)
Novavax 382 367 (96.07%) 8 (2.09%) 3 (0.79%) 4 (1.05%)
Total 464,447 446,480 (96.13%) 1,945 (0.42%) 14,514 (3.13%) 1,508 (0.32%)

Data from Korea Disease Control and Prevention Agency. March 31st, 2022.

Abbreviation: AESI, adverse event special interest; AZ, Oxford/AstraZeneca COVID-19 vaccine; Pfizer, Pfizer-BioNTech COVID-19 vaccine

Biomed Sci Letters 2022;28:67-82 https://doi.org/10.15616/BSL.2022.28.2.67
© 2022 Biomed Sci Letters